MENTICE Aktie

>MENTICE Performance

1 Woche: -5,9%

1 Monat: -15,3%

3 Monate: -1,7%

6 Monate: +15,0%

1 Jahr: -39,9%

laufendes Jahr: -1,7%

>MENTICE Aktie

Name:

MENTICE AB SK -,20

Land:

Schweden

Sektor:

Gesundheit

ISIN/ Wkn:

SE0012673291 / A2PK7M

Symbol/ Ticker:

MN2 (Frankfurt)

Kürzel:

FRA:MN2, ETR:MN2, MN2:GR

Index:

Webseite:

https://www.mentice.com/

Profil:

Mentice AB is a leading provider specializing in high-end solutions for the medical technology field, particularly in healthcare simulation software and related services. Its primary function is to furnish intricate simulation platforms, which assist..
>Volltext..

Marktkapitalisierung:

34.54 Mio. EUR

Unternehmenswert:

33.02 Mio. EUR

Umsatz:

26.16 Mio. EUR

EBITDA:

-0.16 Mio. EUR

Nettogewinn:

-3.03 Mio. EUR

Gewinn je Aktie:

-0.12 EUR

Schulden:

1.58 Mio. EUR

Liquide Mittel:

3.13 Mio. EUR

Operativer Cashflow:

-1.9 Mio. EUR

Bargeldquote:

0.2

Umsatzwachstum:

1.86%

Gewinnwachstum:

-86.01%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

MENTICE

Letzte Datenerhebung:

06.04.26

>MENTICE Kennzahlen

Aktien/ Unternehmen:

Aktien: 28.13 Mio. St.

Frei handelbar: 41.63%

Leerverk. Aktien: -

Rückkaufquote: -8.29%

Mitarbeiter: -

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Neutral

Kursziel: 27.87%

Bewertung:

KGV: -

KGV lG: 113.73

KUV: 1.61

KBV: 2.42

PEG-Ratio: -0.15

EV/EBITDA: -

Rentabilität:

Bruttomarge: -11.85%

Gewinnmarge: -11.59%

Operative Marge: -11.85%

Managementeffizenz:

Gesamtkaprendite: -10.17%

Eigenkaprendite: -22.93%

>MENTICE Peer Group

Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege

>MENTICE Chart & Kurs - Frankfurt
- Boerse Frankfurt
- >Profi Charts

>MENTICE News

02.03.26 - 08:06

Gothenburg leads the way in medical simulation (Cision)

Thanks to advanced simulation technology, doctors can improve their surgical skills more quickly and safely. The technique benefits both patients and society as a whole. Gothenburg-based companies Surgical Science and Mentice are among those driving the development. Maria Zeaiter and Abdelaziz Al-Habali have worked together to thread a thin metal wire, a guidewire, through a long plastic tube. On a screen in front of them, Maria guides the tube, a catheter, through the aorta and towards the heart. Carefully, she advances the guidewire into a coronary artery before sliding a second tube,...

06.11.25 - 11:30	Mentice übertrifft Umsatzerwartungen in Q3 2025 – Aktie steigt um 21 % (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

30.07.25 - 23:48	XFRA: CAPITAL ADJUSTMENT INFORMATION - 31.07.2025 - EQUBF_01 (XETRA)
	Das Instrument MN2 SE0012673291 MENTICE AB SK -,20 EQUITY wird ex Kapitalmassnahme gehandelt am 31.07.2025 The instrument MN2 SE0012673291 MENTICE AB SK -,20 EQUITY is traded ex capital adjustment on 31.07.2025...

09.05.25 - 08:30

Mentice′s CEO to BioStock: “We anticipate a further ramp up in our sales” (Cision)

Mentice reported strong growth in the first quarter of 2025, with revenues reaching SEK 53.3 million – an increase of 19.5 per cent compared to the same period last year. However, profitability was affected by a challenging macroeconomic environment and unfavourable currency effects. BioStock reached out to CEO Frans Venker to learn more about the company's performance and strategic outlook. Läs hela artikeln på biostock.se (https://www.biostock.se/): https://www.biostock.se/2025/05/mentices-ceo-we-anticipate-a-further-ramp-up-in-our-sales/ Detta är ett pressmeddelande från BioStock –...

07.05.25 - 10:36

BioStock: Mentice launches Ankyras in Brazil (Cision)

Mentice has officially launched its treatment planning solution, Ankyras, in Brazil after receiving regulatory clearance from ANVISA, Brazil's National Health Surveillance Agency. According to the company, this marks a significant advancement of intracranial aneurysm care in Latin America, enabling physicians to leverage virtual rehearsal and patient-specific simulation to improve clinical outcomes. Read the full article at biostock.se (https://www.biostock.se/en/): https://www.biostock.se/2025/05/mentice-launches-ankyras-in-brazil/ This is a press release from BioStock - Connecting...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Das sind halt die Freuden eines Preisministers, wenn ab und zu nicht alles teurer wird. - Dr. Josef Staribacher

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram